Document is current
Any future updates will be listed below
-
Authors
Dantas-Torres, Filipe http://orcid.org/0000-0002-1496-6274
Figueredo, Luciana Aguiar
Sales, Kamila Gaudêncio da Silva
Miranda, Débora Elienai de Oliveira
Alexandre, Joanna Lúcia de Almeida
da Silva, Yury Yzabella
da Silva, Lidiane Gomes
Valle, Guilherme Ribeiro
Ribeiro, Vitor Márcio
Otranto, Domenico
Deuster, Katrin
Pollmeier, Matthias
Altreuther, Gertraut
-
Funding
Funding for this research was provided by:
Bayer Animal Health
Conselho Nacional de Desenvolvimento Científico e Tecnológico (313118/2018-3)
Idexx Laboratories
- License Information
-
More Information
Article History
Received: 27 January 2020
Accepted: 1 April 2020
First Online: 21 April 2020
Ethics approval and consent to participate
: The Committee on Ethics in the Use of Animals (CEUA, project number: 66/2014) of the Aggeu Magalhães Institute (Fiocruz) approved the procedures used in this study. Dog owners signed a consent form before the inclusion of their animals in this study.
: Not applicable.
: GA, KD and MP are employees of Bayer Animal Health GmbH. FDT and DO are members of the CVBD World Forum, whose activities are sponsored by Bayer Animal Health. LAF, KGSS, DEOM, JL AA, YYS, LGS, GRV and VMR declare, that they have no competing interests. This study and the publication of this article were sponsored by Bayer Animal Health. IDEXX Laboratories provided the SNAP 4Dx tests.
